Skip to Content

J 267 J 267 (Mycophenolate mofetil 250 mg)

Pill imprint J 267 J 267 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; dermatomyositis; organ transplant, rejection prophylaxis; rheumatoid arthritis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil
J 267 J 267
250 mg
Blue & Orange
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Jubilant Cadista Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.